156 results on '"Franckena M"'
Search Results
2. Comment on: Cryoablation Without Excision for Low-Risk Early-Stage Breast Cancer: 3-Year Interim Analysis of Ipsilateral Breast Tumor Recurrence in the ICE3 Trial
3. Disease-Free Survival of Patients With Muscle-Invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder-Preserving Therapy: A Nationwide Study.
4. Induction therapy with ipilimumab and nivolumab followed by consolidative chemoradiation as organ-sparing treatment in urothelial bladder cancer: study protocol of the INDIBLADE trial
5. PO-1681 MRI for 3D target temperature assessment in hyperthermia of locally advanced cervical cancer
6. ACUTE AND LONG-TERM TOXICITY IN PATIENTS UNDERGOING INDUCTION CHEMOTHERAPY FOLLOWED BY RADIOTHERAPY AND HYPERTHERMIA FOR ADVANCED CERVICAL CANCER: EP425
7. Induction therapy with ipilimumab and nivolumab followed by consolidative chemoradiation as organ-sparing treatment in urothelial bladder cancer:study protocol of the INDIBLADE trial
8. Induction therapy with ipilimumab and nivolumab followed by consolidative chemoradiation as organ-sparing treatment in urothelial bladder cancer: study protocol of the INDIBLADE trial
9. Acute and long-term toxicity in patients undergoing induction chemotherapy followed by thermoradiotherapy for advanced cervical cancer
10. Disease-Free Survival of Patients with Muscle Invasive Bladder Cancer Treated by Radical Cystectomy vs. Bladder-Sparing Therapy at a Nationwide Level
11. 1780TiP A phase II clinical study to assess efficacy of induction ipilimumab/nivolumab to spare the bladder in urothelial bladder cancer (INDI-BLADE)
12. Distant metastasis in patients with cervical cancer after primary radiotherapy with or without chemotherapy and image guided adaptive brachytherapy
13. PO-1518 Reduction of second cancer risks with proton therapy vs photon VMAT in seminoma patients
14. PO-1192 Treatment planning for thermotherapy as adjuvant strategy to breast cancer preoperative radiotherapy
15. Acute and long-term toxicity in patients undergoing induction chemotherapy followed by thermoradiotherapy for advanced cervical cancer
16. A multicenter cohort of patients treated with concurrent chemoradiotherapy for muscle invasive bladder carcinoma: Results of the past 10 years
17. A genomic urine assay to detect urinary tract recurrences in patients with bladder cancer treated with radiotherapy
18. PH-0552 Imaging-based patient selection in MR-guided hyperthermia for locally advanced cervix cancer
19. Benefit of replacing the Sigma-60 by the Sigma-Eye applicator: A Monte Carlo-based uncertainty analysis
20. OC-0064 First clinical results of integrated EM tracking for pre-treatment verification in prostate BT
21. Clinical performance and future potential of magnetic resonance thermometry in hyperthermia
22. PO-1538 Urinary and bowel dysfunction after hypofractionated 20x3 vs 7x6.1 Gy for localized prostate cancer
23. A multi-institution study: comparison of the heating patterns of five different MR-guided deep hyperthermia systems using an anthropomorphic phantom
24. Standardization of patient modeling in hyperthermia simulation studies: introducing the Erasmus Virtual Patient Repository
25. A moderate thermal dose is sufficient for effective free and TSL based thermochemotherapy
26. PO-1220: Organ-preserving treatment for muscleinvasive bladder cancer: outcomes and prognostic factors
27. Local control rate, survival and toxicity of organ-sparing radiation of muscle-invasive bladder cancer: A contemporary series of 248 patients
28. A moderate thermal dose is sufficient for effective free and TSL based thermochemotherapy
29. EP425 Acute and long-term toxicity in patients undergoing induction chemotherapy followed by radiotherapy and hyperthermia for advanced cervical cancer
30. Commentary: The Impact of the Time Interval Between Radiation and Hyperthermia on Clinical Outcome in Patients With Locally Advanced Cervical Cancer
31. The Effect of the Time Interval Between Radiation and Hyperthermia on Clinical Outcome in 400 Locally Advanced Cervical Carcinoma Patients
32. A0905 - A multicenter cohort of patients treated with concurrent chemoradiotherapy for muscle invasive bladder carcinoma: Results of the past 10 years
33. A0896 - A genomic urine assay to detect urinary tract recurrences in patients with bladder cancer treated with radiotherapy
34. OC-0074 Accuracy of an integrated EMT/BT system for dwell-position detection in pelvic BT
35. PO-0823 Relevance of time interval and thermal dose for the clinical outcome of cervical carcinoma patients
36. The Effect of the Time Interval Between Radiation and Hyperthermia on Clinical Outcome in 400 Locally Advanced Cervical Carcinoma Patients
37. Systematic quality assurance of the BSD2000-3D MR-compatible hyperthermia applicator performance using MR temperature imaging
38. Ex vivo assays to predict enhanced chemosensitization by hyperthermia in urothelial cancer of the bladder
39. Deep hyperthermia with the HYPERcollar system combined with irradiation for advanced head and neck carcinoma–a feasibility study
40. Evaluation of MR imaging with diffusion-weighted imaging for the local response assessment of patients treated with chemoradiation for cervical cancer: A multicenter study
41. Deep hyperthermia with the HYPERcollar system combined with irradiation for advanced head and neck carcinoma – a feasibility study
42. The effect of thermal dose on hyperthermia-mediated inhibition of DNA repair through homologous recombination
43. Heat-induced BRCA2 degradation in human tumours provides rationale for hyperthermia-PARP-inhibitor combination therapies
44. Phase I study of cisplatin, hyperthermia, and lapatinib in patients with recurrent carcinoma of the uterine cervix in a previously irradiated area
45. Association of acute adverse effects with high local SAR induced in the brain from prolonged RF head and neck hyperthermia
46. Hyperthermia and the need to monitor temperature
47. OC-0335: Feasibility of deep head and neck hyperthermia
48. PD-0524: Visualization tool for Electromagnetic Dosimetry and Optimization (VEDO) during deep hyperthermia
49. Association of acute adverse effects with high local SAR induced in the brain from prolonged RF head and neck hyperthermia
50. Hyperthermia and the need to monitor temperature.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.